THIS APP HELPS CATCH SEPSIS
Every year, more than 1.5 million Americans develop sepsis, an illness that occurs when the body exhibits an extreme reaction to an infection. This elusive and stubborn condition causes 250,000 deaths annually.Aided by an app: Doctors at Oregon Health & Science University in Portland and engineers at GE Healthcare have partnered to develop an app to lower sepsis risk in hospitals and catch it before it strikes. The software, expected to launch in December, assesses a patient’s sepsis risk as soon as they enter the hospital and assigns them a sepsis risk score to be entered into each patient’s electronic medical record. Unlike other solutions that track sepsis within a single department, like the ICU, GE Healthcare’s app will track the sepsis load across the entire hospital.Read more about the app here.
Cell and gene therapies, especially for cancer, are rapidly changing healthcare, and Key Biologics, a company based in Memphis, Tennessee, is helping the industry move faster by supplying customers with the cellular raw materials they need.
Cool technology: Material consistency is a significant problem for the burgeoning cell-therapy oncology market, which is expected to reach $30 billion by 2030. At the end of 2017, more than 900 clinical trials were in progress. That’s why Key Biologics recently installed a cryogenic cooler from Asymptote — part of GE Healthcare Life Sciences. The controlled-rate freezer cools cellular material from room temperature to below -238 degrees Fahrenheit, ensuring researchers and manufacturers get the high-quality materials they need. Key Biologics president Dr. Edward Scott sees cell therapy as a "new, exciting and potent way to treat diseases for which there’s not, in many cases, a viable alternative.”
Read more about Key Biologics here.
GE recently partnered with the New York Times Magazine to allow readers to explore the world of energy like never before — with their ears. The magazine published the recordings on Saturday.
An energizing experience: The series takes listeners to Germany’s Merkur offshore wind farm populated with 66 GE offshore wind turbines, the Bujagali Hydropower Station in Uganda, which powers almost half of the country, and to a desert substation in northern Chile that helped the local energy company TEN connect two separate power grids that now transmit more than 99% of the country’s electricity.
Listen to the sounds here.
CRYOGENIC COOLER
Cell and gene therapies, especially for cancer, are rapidly changing healthcare, and Key Biologics, a company based in Memphis, Tennessee, is helping the industry move faster by supplying customers with the cellular raw materials they need.
Cool technology: Material consistency is a significant problem for the burgeoning cell-therapy oncology market, which is expected to reach $30 billion by 2030. At the end of 2017, more than 900 clinical trials were in progress. That’s why Key Biologics recently installed a cryogenic cooler from Asymptote — part of GE Healthcare Life Sciences. The controlled-rate freezer cools cellular material from room temperature to below -238 degrees Fahrenheit, ensuring researchers and manufacturers get the high-quality materials they need. Key Biologics president Dr. Edward Scott sees cell therapy as a "new, exciting and potent way to treat diseases for which there’s not, in many cases, a viable alternative.”
Read more about Key Biologics here.
LISTENING TO ELECTRICITY
GE recently partnered with the New York Times Magazine to allow readers to explore the world of energy like never before — with their ears. The magazine published the recordings on Saturday.
An energizing experience: The series takes listeners to Germany’s Merkur offshore wind farm populated with 66 GE offshore wind turbines, the Bujagali Hydropower Station in Uganda, which powers almost half of the country, and to a desert substation in northern Chile that helped the local energy company TEN connect two separate power grids that now transmit more than 99% of the country’s electricity.
Listen to the sounds here.
— VIDEO OF THE WEEK —
GE Healthcare is helping a Swedish biotech company that developed a process that involves engineering proteins inside high-tech vats called bioreactors to create an environment in which stem cells turn into heart cells, rod and cone cells, and even neurons.— QUOTE OF THE DAY —
“Sepsis is difficult to diagnose, and if not treated early, is associated with high mortality rates.”
— Dr. Matthias Merkel, medical director of adult critical care and chief medical capacity officer at Oregon Health & Science University
Quote: GE Reports. Images: GE Reports.
Subscribe to The GE Brief here.